Mediator release after endobronchial antigen challenge in patients with respiratory allergy.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Journal of Allergy and Clinical Immunology

• Publication date

  1990-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0091-6749(90)90076-GPMID 1692050
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mediator release after nasal airway challenge with allergen.

  2015cited by this paper
• Evidence of PAF-acether metabolic pathway activation in antigen challenge of upper respiratory airways.

  1989cited by this paper
• Release of leukotrienes in patients with bronchial asthma.

  1988cited by this paper
• Generation of leukotriene B4 by human lung fragments and purified human lung mast cells.

  1988cited by this paper
• Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with methacholine bronchial hyperresponsiveness.

  1987cited by this paper
• Behavior and clinical relevance of histamine and leukotrienes C4 and B4 in grass pollen-induced rhinitis.

  1987cited by this paper
• Bronchoconstrictor effects of leukotriene E4 in normal and asthmatic subjects.

  1987cited by this paper
• Anatomical distribution of bronchoalveolar lavage fluid as assessed by digital subtraction radiography.

  1987cited by this paper
• Antigenic release of paf-acether and beta-glucuronidase from alveolar macrophages of asthmatics.

  1987cited by this paper
• Release of prostaglandin D2 into human airways during acute antigen challenge.

  1986cited by this paper
• Development of a radioimmunoassay for prostaglandin D2 using an antiserum against 11-methoxime prostaglandin D2.

  1986cited by this paper
• Immunoglobulin E-dependent stimulation of human alveolar macrophages: significance in type 1 hypersensitivity.

  1986cited by this paper
• Airway responsiveness to leukotrienes C4 and D4 and to methacholine in patients with asthma and normal controls.

  1986cited by this paper
• Characterization of inflammatory mediator release from purified human lung mast cells.

  1986cited by this paper
• Effect of bronchial lavage volume on cellular and protein recovery.

  1985cited by this paper
• Effects of histamine on lung permeability in normal and asthmatic subjects.

  1985cited by this paper
• Eosinophils, bronchial hyperreactivity and late‐phase asthmatic reactions

  1985cited by this paper
• Allergen‐Induced Release of Sulphidopeptide Leukotrienes (SRS‐A) and LTB4 in Allergic Rhinitis

  1985cited by this paper
• Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay.

  1985cited by this paper
• Analysis of cyclooxygenase and lipoxygenase products in incubation media

  1984cited by this paper
• Leukocyte activation in allergen-induced late-phase asthmatic reactions.

  1984cited by this paper
• The bronchoconstrictor effect of inhaled prostaglandin D2 in normal and asthmatic men.

  1984cited by this paper
• Preferential generation of leukotriene C4 by human eosinophils.

  1984cited by this paper
• Mast cells in bronchoalveolar lumen of patients with bronchial asthma.

  1984cited by this paper
• Peptide leukotriene release after antigen challenge in patients sensitive to ragweed.

  1984cited by this paper
• Synthesis of leukotriene B4, and prostanoids by human alveolar macrophages: analysis by gas chromatography/mass spectrometry.

  1984cited by this paper
• The role of mast cells in asthma.

  1983cited by this paper
• Measuring leukotrienes of slow reacting substance of anaphylaxis: development of a specific radioimmunoassay.

  1983cited by this paper
• Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen.

  1983cited by this paper
• Stimulation of alveolar macrophages in asthmatic patients after local provocation test.

  1983cited by this paper
• Mediator release after nasal airway challenge with allergen.

  1983cited by this paper
• Bronchoconstrictor effects of leukotriene C in humans.

  1982cited by this paper
• Characterization of Fc receptors for IgE on human alveolar macrophages.

  1982cited by this paper
• Fc receptors for IgE on human and rat eosinophils.

  1981cited by this paper
• Radioimmunoassay of the leukotrienes of slow reacting substance of anaphylaxis.

  1981cited by this paper
• A laminar flow superfusion technique with much increased sensitivity for the detection of smooth muscle-stimulating substances.

  1976cited by this paper
• An automated continuous-flow system for the extraction and fluorometric analysis of histamine.

  1974cited by this paper
• Bronchial Hyperreactivity to Prostaglandin F2α and Histamine in Patients with Asthma

  1973cited by this paper

• From Pathogenesis to Treatment: Targeting Type-2 Inflammation in Eosinophilic Esophagitis

  2024cites this paper
• Design, Synthesis, and Optimization of Indole Acetic Acid Derivatives as Potent and Selective CRTH2 Receptor Antagonists: Discovery of ACT‐774312

  2023cites this paper
• Inflammation in Asthma Pathogenesis: Role of T cells, Macrophages, Epithelial Cells and Type 2 Inflammation.

  2021cites this paper
• The Role of T Cells and Macrophages in Asthma Pathogenesis: A New Perspective on Mutual Crosstalk

  2020cites this paper
• Chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) antagonists in asthma: a systematic review and meta-analysis protocol

  2018cites this paper
• Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy

  2016cites this paper
• Fevipiprant ( QAW 039 ) , a Slowly Dissociating CRTh 2 Antagonist with the Potential for Improved Clinical Efficacy s

  2016cites this paper
• Leukocyte chemoattractant receptors in human disease pathogenesis.

  2015cites this paper
• Inhibition of antigen-induced airway inflammation and hyperresponsiveness in guinea pigs by a selective antagonist of "chemoattractant receptor homologous molecule expressed on Th2 cells" (CRTH2).

  2013cites this paper
• [Functions of prostaglandin receptors in contact dermatitis and application to drug discovery].

  2012cites this paper
• Benzodiazepinone Derivatives as CRTH2 Antagonists.

  2011cites this paper
• Pharmacological Characterization of MK-7246, a Potent and Selective CRTH2 (Chemoattractant Receptor-Homologous Molecule Expressed on T-Helper Type 2 Cells) Antagonist

  2011cites this paper
• FcεRI, but not FcγR, signals induce prostaglandin D2 and E2 production from basophils.

  2011cites this paper
• Role of hematopoietic prostaglandin D synthase in biphasic nasal obstruction in guinea pig model of experimental allergic rhinitis.

  2011cites this paper
• Discovery of MK-7246, a selective CRTH2 antagonist for the treatment of respiratory diseases.

  2011cites this paper
• Dual functions of prostaglandin D2 in murine contact hypersensitivity via DP and CRTH2.

  2011cites this paper
• Distinct roles of prostaglandin D2 receptors in chronic skin inflammation.

  2011cites this paper
• Immunopathology and Infectious Diseases Dendritic Cells Express Hematopoietic Prostaglandin D Synthase and Function as a Source of Prostaglandin D 2 in the Skin

  2010cites this paper
• Nasal challenge tests with allergens versus other allergy and rhinitis diagnostic tests

  2010cites this paper
• Discovery and optimization of CRTH2 and DP dual antagonists.

  2009cites this paper
• Antagonism of CRTH2 ameliorates chronic epicutaneous sensitization-induced inflammation by multiple mechanisms.

  2009cites this paper
• Effects of Anti-Asthma Agents on Cytokine and Prostaglandin Production in Ovalbumin-Sensitized Splenocytes

  2009cites this paper
• Tetrahydroquinoline derivatives as CRTH2 antagonists.

  2009cites this paper
• Shortening of the induction period of allergic asthma in cynomolgus monkeys by Ascaris suum and house dust mite.

  2008cites this paper
• Increased expression of hematopoietic prostaglandin D synthase in CCR4-positive T cells from patients with atopic dermatitis.

  2008cites this paper
• CRTH2 antagonism significantly ameliorates airway hyperreactivity and downregulates inflammation-induced genes in a mouse model of airway inflammation.

  2008cites this paper
• Sequential induction of pro- and anti-inflammatory prostaglandins and peroxisome proliferators-activated receptor-gamma during normal wound healing: a time course study.

  2007cites this paper
• Presence and Characterization of Prostaglandin D2–Related Molecules in Nasal Mucosa of Patients with Allergic Rhinitis

  2006cites this paper
• This information is current as via CRTH 2 Receptor Chronic Allergic Inflammation of the Skin Plays an Essential Role in 2 Prostaglandin

  2006cites this paper
• Prostaglandin D2 Plays an Essential Role in Chronic Allergic Inflammation of the Skin via CRTH2 Receptor1

  2006cites this paper
• Cutting Edge: Chemoattractant Receptor-Homologous Molecule Expressed on TH2 Cells Plays a Restricting Role on IL-5 Production and Eosinophil Recruitment

  2005cites this paper
• Airway generation‐specific differences in the spatial distribution of immune cells and cytokines in allergen‐challenged rhesus monkeys

  2005cites this paper
• This information is current as Production and Eosinophil Recruitment TH 2 Cells Plays a Restricting Role on IL-5 onReceptor-Homologous Molecule Expressed Cutting Edge : Chemoattractant

  2005cites this paper
• Cysteinyl leukotrienes in porcine acute allergic airway reactions: bronchial and vascular effects

  2003cites this paper
• Prostaglandin D2 Reinforces Th2 Type Inflammatory Responses of Airways to Low-dose Antigen through Bronchial Expression of Macrophage-derived Chemokine

  2003cites this paper
• Pronounced Eosinophilic Lung Inflammation and Th2 Cytokine Release in Human Lipocalin-Type Prostaglandin D Synthase Transgenic Mice1

  2002cites this paper
• Prostaglandin D2 inhibits fibroblast migration

  2002cites this paper
• Göğüsün Allerjik Hastalıklarında Bronkoalveolar Lavajın (BAL) Yeri-1: Astım ve BAL

  2002cites this paper
• Allergic asthma induced in rhesus monkeys by house dust mite (Dermatophagoides farinae).

  2001cites this paper
• Transgenic Mice Lipocalin-Type Prostaglandin D Synthase and Th2 Cytokine Release in Human Pronounced Eosinophilic Lung Inflammation

  2001cites this paper
• Sputum cysteinyl leukotrienes increase 24 hours after allergen inhalation in atopic asthmatics.

  2000influential citation
• Leukotrienes and allergic asthma

  1999cites this paper
• Granulocyte–macrophage colony‐stimulating factor and interleukin‐3 cause basophil histamine release by a common pathway: downregulation by sodium

  1999cites this paper
• Novel Inhibitors of Leukotrienes

  1999cites this paper
• Inhibitors of leukotrienes: An overview

  1999cites this paper
• Leukotrienes in airways obstruction and inflammation evoked by allergen

  1998cites this paper
• Effect of zafirlukast (Accolate) on cellular mediators of inflammation: bronchoalveolar lavage fluid findings after segmental antigen challenge.

  1998cites this paper
• Leukotrienes: lipid bioeffectors of inflammatory reactions.

  1998cites this paper
• Effect of inhaled prostaglandin D2 in normal and atopic subjects, and of pretreatment with leukotriene D4.

  1997cites this paper
• Comparative analysis of isolated human bronchi contraction and biosynthesis of cysteinyl leukotrienes using a direct 5-lipoxygenase inhibitor.

  1997cites this paper
• Eicosanoid mediator expression in mononuclear and polymorphonuclear cells in normal subjects and patients with atopic asthma and cystic fibrosis.

  1996cites this paper
• Safety aspects of local endobronchial allergen challenge in asthmatic patients.

  1996cites this paper
• Role of mast cells and basophils in asthma.

  1995cites this paper
• Evaluation of dust and dust mite nasal provocation.

  1995cites this paper
• Synthesis, structure-activity relationships, and pharmacological evaluation of pyrrolo[3,2,1-ij]quinoline derivatives: potent histamine and platelet activating factor antagonism and 5-lipoxygenase inhibitory properties. Potential therapeutic application in asthma.

  1995cites this paper
• Diurnal variation of urinary leukotriene E4 and histamine excretion rates in normal subjects and patients with mild-to-moderate asthma.

  1995cites this paper
• Furosemide attenuates bronchial responsiveness to antigen challenge "in vitro".

  1995cites this paper
• Allergen-induced llate-phase a airways o obstruction iin tthe p pig: mediator rrelease a and e eosinophil rrecruitment

  1995cites this paper
• Release of mast-cell-derived mediators after endobronchial adenosine challenge in asthma.

  1995cites this paper
• Allergen-induced late-phase airways obstruction in the pig: mediator release and eosinophil recruitment.

  1995cites this paper
• The airway inflammatory response in allergic asthma and its relationship to clinical disease

  1995cites this paper
• Substance P and alveolar macrophages: effects on oxidative metabolism and eicosanoid production

  1995cites this paper
• Mast cell and histamine involvement in farmer's lung disease.

  1994cites this paper
• Effect of a 5‐lipoxygenase inhibitor and leukotriene antagonist (PF 5901) on antigen‐induced airway responses in neonatally immunized rabbits

  1994cites this paper
• 44 – Mucosal Immune Function in Asthma

  1994cites this paper
• Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge.

  1994cites this paper
• An improved assay for urinary LTE4.

  1994cites this paper
• Leukotriene Receptor Antagonists and Biosynthesis Inhibitors in Asthma

  1994cites this paper
• Arachidonic acid metabolism in alveolar macrophages from actively sensitized guinea-pigs: effects of sensitization and specific allergen.

  1994cites this paper
• Methods in Asthmology

  1993cites this paper
• Effect of oral and inhaled cetirizine in allergen induced bronchoconstriction

  1993cites this paper
• Investigative use of fibreoptic bronchoscopy for local airway challenge in asthma.

  1993cites this paper
• Role of the kinin‐kallikrein pathway in allergic diseases

  1993cites this paper
• Inhibition of leukotriene synthesis: new therapy in asthma?

  1993cites this paper
• Bronchoalveolar Lavage in Asthma

  1993cites this paper
• Effect of antigen dose on the recruitment of inflammatory cells to the lung by segmental antigen challenge.

  1992cites this paper
• House dust mite exposure as a cause of asthma

  1992cites this paper
• Effects of a thromboxane-receptor antagonist, BAY u 3405, on prostaglandin D2- and exercise-induced bronchoconstriction.

  1992cites this paper
• Urinary LTE4 excretion in antigen‐provoked asthmatic patients treated with the inhaled LTD4 antagonist, L‐648,051

  1992cites this paper
• Investigative use of bronchoscopy, lavage and bronchial biopsies in asthma and other airways diseases.

  1992cites this paper
• Effect of a 5‐lipoxygenase inhibitor and leukotriene antagonist (PF 5901) on PAF‐induced airway responses in neonatally immunized rabbits

  1992cites this paper
• Urinary leukotriene E4 after exercise challenge in children with asthma.

  1992cites this paper
• Asthma Treatment

  1992cites this paper
• Bronchoalveolar Lavage: Its Application in Asthma

  1992cites this paper
• Studies on the metabolism of eicosanoids with respect to their roles in the human lung.

  1991cites this paper
• Investigative use of bronchoscopy, lavage and bronchial biopsies in asthma and other airways diseases.

  1991cites this paper
• Workshop Summary and Guidelines

  1991cites this paper
• Neural control of human nasal secretion.

  1991cites this paper
• Indoor air pollution: an edifice complex.

  1991cites this paper
• Protection against allergen-induced asthma by salmeterol.

  1990cites this paper
• Eicosanoid mediator expression Table 1 Characteristics of subjects in the three study groups Sex Age Atopy Inhaled WCC Eosinophils IgE FEV

  year unknowncites this paper